The evolution of therapeutic modalities drives the adoption of single-use technologies.

Review of SUT Adoption in Biopharma Manufacturing

Despite a growing number of biosimilar approvals, market uptake remains a challenge.

Moving Biosimilars Forward in a Hesitant Market

Given the criticality of fill/finish processes, it is clear that automation is the next technological step.

Automating the Future of Fill/Finish

Topic

Patrick Lavery is an Editor for the MJH Life Sciences brands Pharmaceutical Technology and BioPharm International, and their respective websites, 

. He previously spent nearly a decade as a news anchor, reporter, and producer at New Jersey 101.5 FM.

Articles

The latest developments in emerging therapies, including new innovations and collaborative efforts in manufacturing.

Update on Trends in Emerging Therapies and Manufacturing

Chris Spivey is the editorial director of 

Videos

Ecolab's Hayley Crowe, executive vice-president and general manager Global Life Sciences sat down at BIO 2024 to discuss technology innovations and how they have enhanced downstream bioprocessing.

A Look Into Bioprocessing Innovations for Downstream Processing Efficiencies (BIO 2024)

Feliza Mirasol is the science editor for 

Lilly has increased its manufacturing investment for biologics in Limerick, Ireland, by $1 billion while launching its new $800 million facility in Kinsale.

Lilly Plans to Grow its Biologics Manufacturing Footprint in Ireland with $1.8 Billion Expansion

During a presentation at the PDA/FDA Joint Regulatory Conference, Nicholas Violand of Johnson & Johnson and Paul Palmer of Paul R. Palmer Limited discussed how aging facilities can impact the quality of pharmaceutical products.

PDA/FDA Joint Regulatory Conference: Product Quality Risk in Aging Facilities

The new Vivaflow SU tangential flow filtration cassette is designed to be more flexible and user-friendly and offers enhanced ultrafiltration and diafiltration efficiency. 

Sartorius Launches Next-Generation TFF Cassette for Streamlining Laboratory Workflows

Martin Kellerer Wåhlander is senior specialist–Materials and Coatings at Alfa Laval Technologies.

Michael Creese is director of Chemical Analysis at Smithers MDT Limited.

Pontus Linderholm is R&D manager at Alfa Laval Technologies.

This case study describes how the risk assessment of the first-to-market single-use disc-stack centrifuge was conducted. 

Extractables Protocol for Single-Use Disc-Stack Separators

Cynthia A. Challener, PhD, is a contributing editor to BioPharm International.

Platform processes and effective risk assessments help overcome time and cost challenges.

Considering Process Scaling for Monoclonal Antibodies During Early Phase Development

Viral vectors and other complex biologic modalities require more specificity and higher sensitivity to detect and distinguish contaminants.

Meeting Adventitious Agent Testing Needs for Complex Modalities

Rentschler Biopharma now offers a new lentiviral vector manufacturing toolbox at its site in Stevenage, UK.

Rentschler Biopharma Launches New LV Vector Manufacturing Toolbox

Mike Hennessy Jr. is the President and CEO of 

A coordinated and international response is needed to help control the latest mpox outbreak in Africa.